Tenax Therapeutics, Inc. , a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada.
Tenax Therapeutics stock last closed at $0.63, up 13.21% from the previous day, and has decreased 94.99% in one year. It has underperformed other stocks in the Biotechnology industry by 0.71 percentage points. Tenax Therapeutics stock is currently +40.27% from its 52-week low of $0.45, and -96.27% from its 52-week high of $17.00.
As of Mar 21, 2023, there are 2.23M shares of TENX outstanding. The market cap of TENX is $1.42M. In the past 24 hours, 5.57M TENX shares were traded.
You need an online brokerage account to access the NASDAQ market and buy TENX stock.
In our opinion, eToro is the best stock brokerage. Here's why:
Get $10 towards your stock purchase by opening an account with eToro now.
Open eToro AccountNow that you've selected your brokerage, you need to fill out some personal details so you are able to buy TENX today.
Now that you've created your account on the best stock market app, you can securely and quickly fund your account:
Watch this video walkthrough if you need help depositing funds into your brokerage account.
Once you have selected the best place to buy Tenax Therapeutics stock, it's crucial to evaluate their stock before you buy, so you actually understand the risk and upside.
WallStreetZen was created to help part-time investors do more accurate fundamental analysis.
You can see all of the due diligence checks on TENX's stock page.
You can use a variety of different financial metrics, analyses, models, and charts to gauge TENX's true value.
Using relative valuations metrics:
You can access additional valuation analysis on TENX's stock here.
Out of 1 sell side analysts who give recommendations on TENX, the consensus analyst rating on Tenax Therapeutics is a Strong Buy
Please note that analyst forecasts are not recommendations, nor are they investment advice.
Jonathan Aschoff, a bottom 11% analyst from Roth MKM initiates coverage on TENX with a strong buy rating and announces their TENX price target of $6.00, on Mar 7, 2023.
You can dive deeper into what analysts are projecting on the Tenax Therapeutics stock forecast page.
In the last year, insiders at TENX have not bought or sold any shares.
Research more about who owns TENX stock here.
No, Tenax Therapeutics doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
There are two main options:
Click the Open button and eToro will execute your order.
If you require additional info about investing in stocks on eToro, click the helpful video below:
Now that you own some TENX stock, you'll want to stay up-to-date on your new company.
Put TENX on a watchlist to get the latest updates about your TENX stock.
To reiterate, here are the 6 steps you need to take to buy Tenax Therapeutics stock right now:
If you are looking for a brokerage account, eToro is our favorite option.
Get Started with eToro TodayIf you would like to watch your investment in Tenax Therapeutics, click below.